Clinical trial
Galantamine Versus Placebo in Childhood Autism
NCT00252603 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00252603 |
|---|---|
| Title | Galantamine Versus Placebo in Childhood Autism |
| Official title | Galantamine Versus Placebo in Childhood Autism |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | National Alliance for Autism Research |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autism, Childhood Autism |
| Intervention type | Drug |
| Interventions | Galantamine |
| Enrollment | 20 |
| Start date | Apr 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Nov 11, 2005 |
| Last update posted | Jan 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: